المؤلفون: Refolo, P., Sacchini, D., Bloemen, B., Grin, J., Gutierrez-ibarluzea, I., Hofmann, B., Oortwijn, W., Raimondi, C., Sampietro-colom, L., Sandman, Lars, Wilt, G. j. van der, Spagnolo, A. G.

المصدر: European Review for Medical and Pharmacological Sciences. 27(23):11202-11210

وصف الملف: print

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-201198
https://doi.org/10.26355/eurrev_202312_34560

المؤلفون: Guerra, AA, de Lemos, LLP, Godman, B, Bennie, M, Osorio-de-Castro, CGS, Alvares, J, Heaney, A, Vassallo, CA, Wettermark, B, Benguria-Arrate, G, Gutierrez-Ibarluzea, I, Santos, VCC, Petramale, CA, Acurcio, FD

المصدر: International journal of technology assessment in health care. 33(2):279-287

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:136528694

المؤلفون: Maurovich-Horvat P., Bosserdt M., Kofoed K. F., Rieckmann N., Benedek T., Donnelly P., Rodriguez-Palomares J., Erglis A., Stechovsky C., Sakalyte G., Adic N. C., Gutberlet M., Dodd J. D., Diez I., Davis G., Zimmermann E., Kepka C., Vidakovic R., Francone M., Ilnicka-Suckiel M., Plank F., Knuuti J., Faria R., Schroder S., Berry C., Saba L., Ruzsics B., Kubiak C., Gutierrez-Ibarluzea I., Hansen K. S., Muller-Nordhorn J., Merkely B., Knudsen A. D., Benedek I., Orr C., Valente F. X., Zvaigzne L., Suchanek V., Zajanckauskiene L., Adic F., Woinke M., Hensey M., Lecumberri I., Thwaite E., Laule M., Kruk M., Neskovic A. N., Mancone M., Kusmierz D., Feuchtner G., Pietila M., Ribeiro V. G., Drosch T., Delles C., Matta G., Fisher M., Szilveszter B., Larsen L., Ratiu M., Kelly S., del Blanco B. G., Rubio A., Drobni Z. D., Jurlander B., Rodean I., Regan S., Calabria H. C., Boussoussou M., Engstrom T., Hodas R., Napp A. E., Haase R., Feger S., Serna-Higuita L. M., Neumann K., Dreger H., Rief M., Wieske V., Estrella M., Martus P., Dewey M.

المساهمون: Maurovich-Horvat, P., Bosserdt, M., Kofoed, K. F., Rieckmann, N., Benedek, T., Donnelly, P., Rodriguez-Palomares, J., Erglis, A., Stechovsky, C., Sakalyte, G., Adic, N. C., Gutberlet, M., Dodd, J. D., Diez, I., Davis, G., Zimmermann, E., Kepka, C., Vidakovic, R., Francone, M., Ilnicka-Suckiel, M., Plank, F., Knuuti, J., Faria, R., Schroder, S., Berry, C., Saba, L., Ruzsics, B., Kubiak, C., Gutierrez-Ibarluzea, I., Hansen, K. S., Muller-Nordhorn, J., Merkely, B., Knudsen, A. D., Benedek, I., Orr, C., Valente, F. X., Zvaigzne, L., Suchanek, V., Zajanckauskiene, L., Adic, F., Woinke, M., Hensey, M., Lecumberri, I., Thwaite, E., Laule, M., Kruk, M., Neskovic, A. N., Mancone, M., Kusmierz, D., Feuchtner, G., Pietila, M., Ribeiro, V. G., Drosch, T., Delles, C., Matta, G., Fisher, M., Szilveszter, B., Larsen, L., Ratiu, M., Kelly, S., del Blanco, B. G., Rubio, A., Drobni, Z. D., Jurlander, B., Rodean, I., Regan, S., Calabria, H. C., Boussoussou, M., Engstrom, T., Hodas, R., Napp, A. E., Haase, R., Feger, S., Serna-Higuita, L. M., Neumann, K., Dreger, H., Rief, M., Wieske, V., Estrella, M., Martus, P., Dewey, M.

Relation: info:eu-repo/semantics/altIdentifier/pmid/35240010; info:eu-repo/semantics/altIdentifier/wos/WOS:000764276000001; volume:386; issue:17; firstpage:1591; lastpage:1602; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; https://hdl.handle.net/11584/365905

الاتاحة: https://hdl.handle.net/11584/365905
https://doi.org/10.1056/NEJMoa2200963

المؤلفون: Esandi, ME, Gutierrez-Ibarluzea, I, Ibargoyen-Roteta, N, Godman, B

المصدر: International journal of technology assessment in health care. 36(1):50-57

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:143397847

المؤلفون: Van der Wilt, G.J., Bloemen, B., Grin, J., Gutierrez-Ibarluzea, I., Sampietro-Colom, L., Refolo, P., Sacchini, D., Hofmann, B., Sandman, L., Oortwijn, W.

المصدر: Van der Wilt , G J , Bloemen , B , Grin , J , Gutierrez-Ibarluzea , I , Sampietro-Colom , L , Refolo , P , Sacchini , D , Hofmann , B , Sandman , L & Oortwijn , W 2022 , ' Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment : The Values in Doing Assessments of Health Technologies Approach ' , International Journal of Technology Assessment in Health Care , vol. 38 , no. 1 , E52 . https://doi.org/10.1017/S0266462321001768

وصف الملف: application/pdf

Relation: https://dare.uva.nl/personal/pure/en/publications/integrating-empirical-analysis-and-normative-inquiry-in-health-technology-assessment(ee0a1a51-92f1-4897-ada5-b52245a8b8c0).html

الاتاحة: https://dare.uva.nl/personal/pure/en/publications/integrating-empirical-analysis-and-normative-inquiry-in-health-technology-assessment(ee0a1a51-92f1-4897-ada5-b52245a8b8c0).html
https://doi.org/10.1017/S0266462321001768
https://hdl.handle.net/11245.1/ee0a1a51-92f1-4897-ada5-b52245a8b8c0
https://pure.uva.nl/ws/files/111197264/integrating_empirical_analysis_and_normative_inquiry_in_health_technology_assessment_the_values_in_doing_assessments_of_health_technologies_approach.pdf

المؤلفون: Gidding, S. S., Wiegman, A., Groselj, U., Freiberger, T., Peretti, N., Dharmayat, K. I., Daccord, M., Bedlington, N., Sikonja, J., Ray, K. K., Santos, R. D., Halle, M., Tokgözoğlu, L., Gutiérrez-Ibarluzea, I., Pinto, F. J., Geanta, M.

المساهمون: The Familial Hypercholesterolaemia Network Rochester, UK (FH Europe), University of Amsterdam Amsterdam = Universiteit van Amsterdam (UvA), University Medical Centre Ljubljana Ljubljana, Slovenia (UMCL), Masaryk University Brno (MUNI), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Hôpital Femme Mère Enfant CHU - HCL (HFME), Hospices Civils de Lyon (HCL), Imperial College London, Universidade de São Paulo = University of São Paulo (USP), Technische Universität Munchen - Technical University Munich - Université Technique de Munich (TUM), Hacettepe University = Hacettepe Üniversitesi, Basque Foundation for Health Innovation and Research Barakaldo, Spain (BIOEF), Universidade de Lisboa = University of Lisbon = Université de Lisbonne (ULISBOA)

المصدر: ISSN: 2047-4873.

مصطلحات موضوعية: myocardial infarction, LDL cholesterol, cholesterol, familial hypercholesterolaemia, preventive cardiology, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/36059237; inserm-03833176; https://inserm.hal.science/inserm-03833176; https://inserm.hal.science/inserm-03833176/document; https://inserm.hal.science/inserm-03833176/file/zwac200.pdf; PUBMED: 36059237; WOS: 000860847200001

الاتاحة: https://inserm.hal.science/inserm-03833176
https://inserm.hal.science/inserm-03833176/document
https://inserm.hal.science/inserm-03833176/file/zwac200.pdf
https://doi.org/10.1093/eurjpc/zwac200

المؤلفون: Bedlington, N, Abifadel, M, Beger, B, Bourbon, M, Bueno, H, Ceska, R, Cillíková, K, Cimická, Z, Daccord, M, de Beaufort, C, Dharmayat, KI, Ference, BA, Freiberger, T, Geanta, M, Gidding, SS, Groselj, U, Halle, M, Johnson, N, Novakovic, T, Májek, O, Pallidis, A, Peretti, N, Pinto, FJ, Ray, KK, Rees, B, Reeve, J, Reiner, Z, Santos, RD, Schunkert, H, Sikonja, J, Sokolovic, M, Tokgözoglu, L, Vrablík, M, Wiegman, A, Gutiérrez-Ibarluzea, I

المصدر: GMS Health Innovation and Technologies; VOL: 16; DOC04 /20220930/

مصطلحات موضوعية: familial hypercholesterolaemia, FH, screening, children, cardiovascular disease, CVD, prevention, cardiovascular health, CVH, declaration, public health, health systems, EU, Europe, EU best practice, implementation, ddc: 610

Relation: Ademi Z, Norman R, Pang J, Liew D, Zoungas S, Sijbrands E, et al. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment? Atherosclerosis. 2020;304:18. DOI:10.1016/j.atherosclerosis.2020.05.007; Cuchel M, McGowan MP. Familial hypercholesterolaemia: too many lost opportunities. The Lancet. 2021;398(10312):166-78. DOI:10.1016/S0140-6736(21)01372-6; EURORDIS. Czech Deputy Health Minister calls for a European Union Action Plan on rare diseases, as Czechia takes over the EU Presidency. 2022 Jul 1 [cited 2022 Sep 13]. Available from: https://www.eurordis.org/press-release-ecrd-cz-presidency/; European Atherosclerosis Society. Lipid Clinics Network. [cited 2022 Sep 13]. Available from: https://www.eas-society.org/page/lcn_main; European Commission. Proceedings of the Webinar Healthier together: EU non-communicable diseases initiative. 2022 Jun 22 [cited 2022 Sep 13]. Available from: https://health.ec.europa.eu/events/healthier-together-eu-non-communicable-diseases-initiative-2022-06-22_en; European Commission Public Health Best Practice Portal. Selection of best practices in non-communicable disease prevention: Paediatric screening of FH (Familial Hypercholesterolaemia) patients. 2021 [cited 2022 Sep 13]. Available from: https://webgate.ec.europa.eu/dyna/bp-portal/practice.cfm?id=390; Familial Hypercholesterolaemia Australasia Network. The National Familial Hypercholesterolaemia Registry. [cited 2022 Sep 13]. Available from: https://fhregistry-international.com/; Gidding SS, Wiegman A, Groselj U, Freiberger T, Peretti N, Dharmayat KI, et al. Paediatric familial hypercholesterolaemia screening in Europe - Public background and recommendations. Eur J Prev Cardiol. 2022:200. DOI:10.1093/eurjpc/zwac200; Groselj U, Wiegman A, Gidding SS. Screening in children for familial hypercholesterolaemia: start now. Eur Heart J. 2022;22-4. DOI:10.1093/eurheartj/ehac224; Kerr M, Pears R, Miedzybrodzka Z, Haralambos K, Cather M, Watson M, et al. Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK. Eur Heart J. 2017;38(23):1832-9. DOI:10.1093/eurheartj/ehx111; McKay AJ, Hogan H, Humphries SE, Marks D, Ray KK, Miners A. Universal screening at age 12 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis. Atherosclerosis. 2018;275:434-43. DOI:10.1016/j.atherosclerosis.2018.05.047; The Council of the European Union. Council conclusions on personalised medicine for patients, 2015/C 421/03. 2015 Dec 17 [cited 2022 Sep 13]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52015XG1217(01)&from=FR; WHO Human Genetics Programme. Familial hypercholesterolaemia (FH): report of a second WHO consultation, Geneva, 4 September 1998. Geneva: World Health Organization; 1999 [cited 2022 Sep 13]. Available from: https://apps.who.int/iris/handle/10665/66346.; Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, et al. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action. JAMA Cardiol. 2020;5(2):217. DOI:10.1001/jamacardio.2019.5173; World Heart Federation. Improving prevention and control of raised cholesterol: a call to action World Heart federation White Paper. Geneva: World Heart Federation; 2021 [cited 2022 Sep 13]. Available from: https://world-heart-federation.org/resource/whf-cholesterol-white-paper/; http://dx.doi.org/10.3205/hta000136; http://nbn-resolving.de/urn:nbn:de:0183-hta0001369; http://www.egms.de/en/journals/hta/2022-16/hta000136.shtml

الاتاحة: https://doi.org/10.3205/hta000136
http://nbn-resolving.de/urn:nbn:de:0183-hta0001369
http://www.egms.de/en/journals/hta/2022-16/hta000136.shtml

المؤلفون: Gutiérrez-Ibarluzea, I, Ibargoyen-Roteta, N, Benguria-Arrate, G, Galnares-Cordero, L

المصدر: European Journal of Public Health ; volume 32, issue Supplement_3 ; ISSN 1101-1262 1464-360X

الاتاحة: https://doi.org/10.1093/eurpub/ckac129.085
https://academic.oup.com/eurpub/article-pdf/32/Supplement_3/ckac129.085/48593621/ckac129.085.pdf

المؤلفون: Barbaglia, G, García-Abiétar, D, Beltrán-Aguirre, JL, García, AM, García-Armesto, S, Gutiérrez-Ibarluzea, I, Segura-Benedicto, A, Franco-Tejero, M, Urbanos-Garrido, R, Hernández-Aguado, I

المصدر: European Journal of Public Health ; volume 32, issue Supplement_3 ; ISSN 1101-1262 1464-360X

مصطلحات موضوعية: Public Health, Environmental and Occupational Health

الاتاحة: http://dx.doi.org/10.1093/eurpub/ckac131.541
https://academic.oup.com/eurpub/article-pdf/32/Supplement_3/ckac131.541/46587995/ckac131.541.pdf

المؤلفون: Rieckmann N., Neumann K., Feger S., Ibes P., Napp A., Preuss D., Dreger H., Feuchtner G., Plank F., Suchanek V., Veselka J., Engstrom T., Kofoed K. F., Schroder S., Zelesny T., Gutberlet M., Woinke M., Maurovich-Horvat P., Merkely B., Donnelly P., Ball P., Dodd J. D., Hensey M., Loi B., Saba L., Francone M., Mancone M., Berzina M., Erglis A., Vaitiekiene A., Zajanckauskiene L., Haran T., Suckiel M. I., Faria R., Gama-Ribeiro V., Benedek I., Rodean I., Adjic F., Cemerlic Adjic N., Rodriguez-Palomares J., Garcia Del Blanco B., Brooksbank K., Collison D., Davis G., Thwaite E., Knuuti J., Saraste A., Kepka C., Kruk M., Benedek T., Ratiu M., Neskovic A. N., Vidakovic R., Diez I., Lecumberri I., Fisher M., Ruzsics B., Hollingworth W., Gutierrez-Ibarluzea I., Dewey M., Muller-Nordhorn J.

المساهمون: Rieckmann, N., Neumann, K., Feger, S., Ibes, P., Napp, A., Preuss, D., Dreger, H., Feuchtner, G., Plank, F., Suchanek, V., Veselka, J., Engstrom, T., Kofoed, K. F., Schroder, S., Zelesny, T., Gutberlet, M., Woinke, M., Maurovich-Horvat, P., Merkely, B., Donnelly, P., Ball, P., Dodd, J. D., Hensey, M., Loi, B., Saba, L., Francone, M., Mancone, M., Berzina, M., Erglis, A., Vaitiekiene, A., Zajanckauskiene, L., Haran, T., Suckiel, M. I., Faria, R., Gama-Ribeiro, V., Benedek, I., Rodean, I., Adjic, F., Cemerlic Adjic, N., Rodriguez-Palomares, J., Garcia Del Blanco, B., Brooksbank, K., Collison, D., Davis, G., Thwaite, E., Knuuti, J., Saraste, A., Kepka, C., Kruk, M., Benedek, T., Ratiu, M., Neskovic, A. N., Vidakovic, R., Diez, I., Lecumberri, I., Fisher, M., Ruzsics, B., Hollingworth, W., Gutierrez-Ibarluzea, I., Dewey, M., Muller-Nordhorn, J.

مصطلحات موضوعية: angina, chest pain, computed tomography angiography, coronary artery disease, health-related quality of life, invasive coronary angiography, aged, angina pectori, female, human, male, middle aged, pilot project, sex distribution, surveys and questionnaire, quality of life

Relation: info:eu-repo/semantics/altIdentifier/pmid/32410687; info:eu-repo/semantics/altIdentifier/wos/WOS:000536186400001; volume:18; issue:1; numberofpages:10; journal:HEALTH AND QUALITY OF LIFE OUTCOMES; http://hdl.handle.net/11573/1453564; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85084796550

الاتاحة: http://hdl.handle.net/11573/1453564
https://doi.org/10.1186/s12955-020-01312-4

المؤلفون: Rieckmann N., Neumann K., Feger S., Ibes P., Napp A., Preuss D., Dreger H., Feuchtner G., Plank F., Suchanek V., Veselka J., Engstrom T., Kofoed K. F., Schroder S., Zelesny T., Gutberlet M., Woinke M., Maurovich-Horvat P., Merkely B., Donnelly P., Ball P., Dodd J. D., Hensey M., Loi B., Saba L., Francone M., Mancone M., Berzina M., Erglis A., Vaitiekiene A., Zajanckauskiene L., Haran T., Suckiel M. I., Faria R., Gama-Ribeiro V., Benedek I., Rodean I., Adjic F., Adjic N. Ͽ., Rodriguez-Palomares J., Del Blanco B. G., Brooksbank K., Collison D., Davis G., Thwaite E., Knuuti J., Saraste A., Kepka C., Kruk M., Benedek T., Ratiu M., Neskovic A. N., Vidakovic R., Diez I., Lecumberri I., Fisher M., Ruzsics B., Hollingworth W., Gutierrez-Ibarluzea I., Dewey M., Muller-Nordhorn J.

المساهمون: Rieckmann, N., Neumann, K., Feger, S., Ibes, P., Napp, A., Preuss, D., Dreger, H., Feuchtner, G., Plank, F., Suchanek, V., Veselka, J., Engstrom, T., Kofoed, K. F., Schroder, S., Zelesny, T., Gutberlet, M., Woinke, M., Maurovich-Horvat, P., Merkely, B., Donnelly, P., Ball, P., Dodd, J. D., Hensey, M., Loi, B., Saba, L., Francone, M., Mancone, M., Berzina, M., Erglis, A., Vaitiekiene, A., Zajanckauskiene, L., Haran, T., Suckiel, M. I., Faria, R., Gama-Ribeiro, V., Benedek, I., Rodean, I., Adjic, F., Adjic, N. Ͽ., Rodriguez-Palomares, J., Del Blanco, B. G., Brooksbank, K., Collison, D., Davis, G., Thwaite, E., Knuuti, J., Saraste, A., Kepka, C., Kruk, M., Benedek, T., Ratiu, M., Neskovic, A. N., Vidakovic, R., Diez, I., Lecumberri, I., Fisher, M., Ruzsics, B., Hollingworth, W., Gutierrez-Ibarluzea, I., Dewey, M., Muller-Nordhorn, J.

مصطلحات موضوعية: The original version of this article, published on 16 December 2019, unfortunately contained two mistakes. Firstly, the name of Jonathan Dermot Dodd was presented incorrectly. Secondly, the information about the equal contribution of Gianluca De Rubeis and Adriane E. Napp, and Marc Dewey and Marco Francone is missing. The corrected author list is given above and the missing article note below. Furthermore, affiliation 48 from the original version of the article was a duplicate and is therefore removed. © 2020, European Society of Radiology

Relation: info:eu-repo/semantics/altIdentifier/pmid/32600467; info:eu-repo/semantics/altIdentifier/wos/WOS:000546151300001; volume:18; issue:1; journal:HEALTH AND QUALITY OF LIFE OUTCOMES; http://hdl.handle.net/11573/1458766; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087388670

الاتاحة: http://hdl.handle.net/11573/1458766
https://doi.org/10.1186/s12955-020-01443-8

المؤلفون: Hogervorst, M.A., Vreman, R., Heikkinen, I., Bagchi, I., Gutierrez-Ibarluzea, I., Ryll, B., Eichler, H.G., Petelos, E., Tunis, S., Sapede, C., Goettsch, W., Janssens, R., Huys, I., Barbier, L., DeJean, D., Strammiello, V., Lingri, D., Goodall, M., Papadaki, M., Toussi, M., Voulgaraki, D., Mitan, A., Oortwijn, W.J.

المصدر: International Journal of Technology Assessment in Health Care; 0266-4623; 1; 39; e40; ~International Journal of Technology Assessment in Health Care~~~~~0266-4623~1~39~~e40

URL: https://repository.ubn.ru.nl//bitstream/handle/2066/294548/294548.pdf
https://repository.ubn.ru.nl/handle/2066/294548

المؤلفون: Refolo, Pietro, Sacchini, Dario, Bloemen, B, Grin, J, Gutierrez-Ibarluzea, I, Hofmann, B, Oortwijn, W, Raimondi, Costanza, Sampietro-Colom, L, Sandman, L, van der Wilt, G J, Spagnolo, Antonio Gioacchino, Refolo, P (ORCID:0000-0003-1055-160X), Sacchini, D (ORCID:0000-0002-1581-3018), Raimondi, C, Spagnolo, A G (ORCID:0000-0002-5762-2164)

مصطلحات الفهرس: HTA, Settore MED/43 - MEDICINA LEGALE, info:eu-repo/semantics/article

URL: https://hdl.handle.net/10807/259175
info:eu-repo/semantics/altIdentifier/pmid/38095370
volume:27
issue:23
firstpage:11202
lastpage:11210
numberofpages:9
issueyear:2023
journal:EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES

المؤلفون: Migliore, A, Dauben, H, Gutierrez Ibarluzea, I, Kearney, B, Kurylowicz, L, Joppi, R

المصدر: GMS Health Innovation and Technologies; VOL: 15; DOC01 /20190924/

مصطلحات موضوعية: ddc: 610

Relation: http://dx.doi.org/10.3205/hta000131; http://nbn-resolving.de/urn:nbn:de:0183-hta0001318; http://www.egms.de/en/journals/hta/2019-15/hta000131.shtml

الاتاحة: https://doi.org/10.3205/hta000131
http://nbn-resolving.de/urn:nbn:de:0183-hta0001318
http://www.egms.de/en/journals/hta/2019-15/hta000131.shtml

المؤلفون: Chiumente, M, Kamal, KM, Dauben, HP, Riedel, R, Gutierrez-Ibarluzea, I

المصدر: GMS Health Innovation and Technologies; VOL: 15; DOC02 /20190924/

مصطلحات موضوعية: health technology assessment, capacity building, decision making, patient-centred care, continuing medical education, ddc: 610

Relation: Allen N, Liberti L, Walker SR, Salek S. A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment? Front Pharmacol. 2017;8:384. DOI:10.3389/fphar.2017.00384.; HTAi/INAHTA/EuroScan international network glossary. [cited 2017 Oct 13]. Available from: http://htaglossary.net; Moscow metro map. [cited 2017 Oct 13]. Available from: http://mosmetro.ru/metro-map/; Benoit C, Gorry P. Health technology assessment: the scientific career of a policy concept. Int J Technol Assess Health Care. 2017;33(1):128-134. DOI:10.1017/S0266462317000186; Bodenheimer T. High and rising health care costs. Part 2: technologic innovation. Ann Intern Med. 2005;142(11):932-937. DOI:10.7326/0003-4819-142-11-200506070-00012; De Meijer C, Wouterse B, Polder J, Koopmanschap M. The effect of population aging on health expenditure growth: a critical review. Eur J Ageing. 2013;10(4):353-361. DOI:10.1007/s10433-013-0280-x; Fineberg, HV. A Successful and Sustainable Health System - How to Get There from Here. N Engl J Med. 2012;366(11):1020-1027. DOI:10.1056/NEJMsa1114777; Gutiérrez-Ibarluzea I, Chiumente M, Dauben HP. The Life Cycle of Health Technologies. Challenges and Ways Forward. Front Pharmacol. 2017;8:14. DOI:10.3389/fphar.2017.00014; Kaló Z, Gheorghe A, Huic M, Csanádi M, Kristensen FB. HTA Implementation Roadmap in Central and Eastern European Countries. Health Econ. 2016;25 Suppl 1:179-192. DOI:10.1002/hec.3298; Lampe K, Mäkelä M, Garrido MV, Anttila H, Autti-Rämö I, Hicks NJ, et al. The HTA core model: a novel method for producing and reporting health technology assessments. Int J Technol Assess Health Care. 2009; 25 Suppl 2:9-20. DOI:10.1017/S0266462309990638; Mueller D, Gutiérrez-Ibarluzea I, Schuller T, Chiumente M, Ahn J, Pichon-Riviere A, et al. Capacity building in agencies for efficient and effective health technology assessment. Int J Technol Assess Health Care. 2016;32(4):292-299. DOI:10.1017/S0266462316000490; Zechmeister-Koss I, Schnell-Inderst P, Zauner G. Appropriate evidence sources for populating decision analytic models within health technology assessment (HTA): a systematic review of HTA manuals and health economic guidelines. Med Decis Making. 2014;34(3):288-299. DOI:10.1177/0272989X13509406; http://dx.doi.org/10.3205/hta000132; http://nbn-resolving.de/urn:nbn:de:0183-hta0001328; http://www.egms.de/en/journals/hta/2019-15/hta000132.shtml

الاتاحة: https://doi.org/10.3205/hta000132
http://nbn-resolving.de/urn:nbn:de:0183-hta0001328
http://www.egms.de/en/journals/hta/2019-15/hta000132.shtml

المؤلفون: Jameleddine, M., Grati, H., Jebali, M.C., Kouki, M., Gutierrez-Ibarluzea, I., Toumi, M., Zghal, K.

المصدر: Value in Health ; volume 22, page S511 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2019.09.577
https://api.elsevier.com/content/article/PII:S1098301519329559?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301519329559?httpAccept=text/plain

المؤلفون: Ibargoyen-Roteta, N, Mateos del Pino, M, Gutiérrez-Ibarluzea, I, Benguria-Arrate, G, Rada-Fernández de Jauregui, D, Domingo-Rico, C, Regidor Fuentes, I, González Santisteban, R, Armendáriz Cuñado, M, Jaio Atela, N

المصدر: GMS Health Technology Assessment; VOL: 14; DOC01 /20181105/

مصطلحات موضوعية: de-prescription, disinvestment, SYSADOA, chondroitin sulfate, diacerein, glucosamine, osteoarthritis, ddc: 610

Relation: Agencia Española de Medicamentos y Productos Sanitarios, Ministerio de Sanidad, Servicios Sociales e Igualdad. Informe de utilización de medicamentos U/AIN/V1/15012014. Utilización de medicamentos antiinflamatorios no esteroides (AINE) en España durante el periodo 2000-2012. 2014 Jan 27. Available from: http://aemps.gob.es/medicamentosUsoHumano/observatorio/docs/AINE.pdf; Ficha de evaluación terapéutica. Condroitín sulfato/Glucosamina (Droglican®) en artrosis. 2012 Mar. Available from: https://www.navarra.es/NR/rdonlyres/DABD1CC5-ED2A-496C-AE4D-D2FC34091E94/208204/FET_2012_3.pdf; Bae S, Kim S, Sung Y, et al. Effectiveness of Glucosamine/Condroitin in Osteoarthritis. NECA HTA Report NA 09-004. Seoul, Korea: NECA; 2009.; Bernal-Delgado E, García-Armesto S, Campillo-Artero C. Sirven los estudios de variabilidad geográfica de la práctica para informar la desinversión? Varias cautelas y algunas reflexiones [Are studies of geographical variation in medical practice useful in guiding decisions on disinvestment? Some pros and cons]. Gac Sanit. 2013 Jan-Feb;27(1):7-11. DOI:10.1016/j.gaceta.2012.02.004; Calvo Pita C. Fármacos sintomáticos de acción lenta y administración oral para la artrosis: dudosa eficacia en el control sintomatico y nula actividad condroprotectora. El Comprimido. 2010;18:1-7.; Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006 Feb 23;354(8):795-808. DOI:10.1056/NEJMoa052771; Comité de evaluación de nuevos medicamentos de Euskadi. Informe de Evaluación. Condroitín sulfato/glucosamina. Nuevo medicamento a examen No. 189. 2012. Available from: https://www.euskadi.eus/contenidos/informacion/medicamentos_atencion_primaria/es_def/adjuntos/C/condroitin-sulfato-glucosamina/condroitin sulfato_glucosamina_ficha_c.pdf; Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE. Identifying existing health care services that do not provide value for money. Med J Aust. 2009 Mar 2;190(5):269-73.; Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003 Feb 18;138(4):273-87. DOI:10.7326/0003-4819-138-4-200302180-00006; Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003 Feb 18;138(4):288-98. DOI:10.7326/0003-4819-138-4-200302180-00007; Gabbay J, le May A. Evidence based guidelines or collectively constructed "mindlines?" Ethnographic study of knowledge management in primary care. BMJ. 2004 Oct 30;329(7473):1013. DOI:10.1136/bmj.329.7473.1013; Gutiérrez-Ibarluzea I, Ibargoyen-Roteta N, Benguria-Arrate G, Rada D, Mateos M, Regidor I, Domingo C, González R, Galnares-Cordero L. Sysadoas. Condroprotectores en el tratamiento de la artrosis. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación de Tecnologías Sanitarias del País Vasco; 2013. (Informes de Evaluación de Tecnologías Sanitarias: OSTEBA).; Gutiérrez-Ibarluzea I, Ibargoyen-Roteta N, Mateos-del Pino M, Benguria-Arrate G, Regidor-Fuentes I, Domingo-Rico C, González-Santisteban R, Rada-Fdz de Jauregi D. P168 Practice guidelines and professional mind-lines. Qualitative research on sysadoas for osteoarthritis. BMJ Qual Saf. 2013;22(Suppl 1):A1-A94. DOI:10.1136/bmjqs-2013-002293.190; Heller L. US glucosamine grows slow, lags global sales. 2009 Mar 02. Available from: https://www.nutraingredients-usa.com/Article/2009/03/02/US-glucosamine-grows-slow-lags-global-sales; Isasi Zaragoza C, Alcaraz Borrajo M, Sanz Sanz J. Fármacos de acción lenta para el tratamiento de la artrosis. Inf Ter Sist Nac Salud. 2004;28(6):145-50.; Jüni P, Reichenbach S, Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol. 2006 Aug;20(4):721-40. DOI:10.1016/j.berh.2006.05.002; Kim G, Park S, Hong S, et al. Clinical effectiveness of glucosamine for patients with osteoarthritis. NECA Rapid Review Report 11-002. Seoul, Korea: NECA; 2011.; Laegemiddelstyrelsen - Danish Medicines Agency. The reimbursement for glucosamine is removed on 28 November 2011. 2011 Oct 4. Available from: https://laegemiddelstyrelsen.dk/en/news/Nyheder revurdering tilskud arkiv/the-reimbursement-for-glucosamine-is-removed-on-28-november-2011; McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000 Mar 15;283(11):1469-75. DOI:10.1001/jama.283.11.1469; Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Bürgi E, Scherer M, Altman DG, Jüni P. The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ. 2009 Sep 7;339:b3244. DOI:10.1136/bmj.b3244; Nüesch E, Reichenbach S, Trelle S, Rutjes AW, Liewald K, Sterchi R, Altman DG, Jüni P. The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis Rheum. 2009 Dec 15;61(12):1633-41. DOI:10.1002/art.24894; Reichenbach S, Sterchi R, Scherer M, Trelle S, Bürgi E, Bürgi U, Dieppe PA, Jüni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007 Apr 17;146(8):580-90. DOI:10.7326/0003-4819-146-8-200704170-00009; Rozendaal RM, Koes BW, van Osch GJ, Uitterlinden EJ, Garling EH, Willemsen SP, Ginai AZ, Verhaar JA, Weinans H, Bierma-Zeinstra SM. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med. 2008 Feb 19;148(4):268-77. DOI:10.7326/0003-4819-148-4-200802190-00005; Sanfélix-Gimeno G, Peiró S, Librero J; Grupo de Investigación en Utilización de Medicamentos en el Sistema Nacional de Salud (Grupo IUM-SNS) de la Comunidad Valenciana. Variabilidad en la utilización de antihipertensivos entre las zonas básicas de salud de la Comunidad Valenciana [Variations in antihypertensive drug utilization among primary care areas in the autonomous region of Valencia (Spain)]. Gac Sanit. 2010 Sep-Oct;24(5):397-403. DOI:10.1016/j.gaceta.2010.05.004; Tandvårds- och läkemedelsförmånsverket. Glukosamin utesluts ur högkostnadsskyddet - Delbeslut i genomgången av smärtstillande och inflammationsdämpande läkemedel [Glucosamine excluded from the reimbursement system - Interim decision from the review of painkillers and anti-inflammatory medicines]. Solna: TVL; 2010. Available from: https://www.tlv.se/download/18.467926b615d084471ac33d03/1510316367373/sammanfattning/dglukosaminer-100216.pdf; Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, Hochberg MC, Wells G. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946. DOI:10.1002/14651858.CD002946.pub2; Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum. 2007 Jul;56(7):2267-77. DOI:10.1002/art.22728; Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010 Sep 16;341:c4675. DOI:10.1136/bmj.c4675; http://dx.doi.org/10.3205/hta000130; http://nbn-resolving.de/urn:nbn:de:0183-hta0001306; http://www.egms.de/en/journals/hta/2018-14/hta000130.shtml

الاتاحة: https://doi.org/10.3205/hta000130
http://nbn-resolving.de/urn:nbn:de:0183-hta0001306
http://www.egms.de/en/journals/hta/2018-14/hta000130.shtml

المؤلفون: Portillo, I, Idigoras, I, Bilbao, I, Arana-Arri, E, Gutierrez-Ibarluzea, I, Bujanda, L, Imaz, N, Martínez-Indart, L, Unanue, S, Mendizabal, N, Fernández-Landa, MJ, Bilbao, JL

المصدر: European Journal of Public Health ; volume 28, issue suppl_4 ; ISSN 1101-1262 1464-360X

الاتاحة: https://doi.org/10.1093/eurpub/cky212.448
http://academic.oup.com/eurpub/article-pdf/28/suppl_4/cky212.448/26616141/cky212.448.pdf

المؤلفون: Ballini, L., Bonvicini, L., Bottazzi, P., Eisenmann, A., Formoso, G., Giorgi Rossi, P., Rosian-Schikuta, I., Venturelli, F., Vicentini, M., De Laet, C., Ibargoyen, N., Gutierrez Ibarluzea, I., Gimenez, E., García-Pérez, L.

المصدر: Value in Health ; volume 21, page S202 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2018.09.1200
https://api.elsevier.com/content/article/PII:S1098301518345029?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301518345029?httpAccept=text/plain

المؤلفون: Godman, B, Malmstrom, RE, Diogene, E, Jayathissa, S, McTaggart, S, Cars, T, Alvarez-Madrazo, S, Baumgartel, C, Brzezinska, A, Bucsics, A, Campbell, S, Eriksson, I, Finlayson, A, Furst, J, Garuoliene, K, Gutierrez-Ibarluzea, I, Hviding, K, Herholz, H, Joppi, R, Kalaba, M, Laius, O, Malinowska, K, Pedersen, HB, Markovic-Pekovic, V, Piessnegger, J, Selke, G, Sermet, C, Spillane, S, Tomek, D, Voncina, L, Vlahovic-Palcevski, V, Wale, J, Wladysiuk, M, van Woerkom, M, Zara, C, Gustafsson, LL

المصدر: Frontiers in pharmacology. 5:109

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:130395923